Précis: Inhibition of C5a relieved MDSCmediated immunosuppression to enhance the efficacy of PD-1 blockade, thereby extending survival in mouse models of lung cancer and reducing primary and metastatic tumor growth .
Précis: In AML patient-derived xenografts, treatment with the chemotherapeutic cytarabine selected for a resistant population exhibiting enhanced oxidative phosphorylation, but did not select for quiescent leukemic stem cells . Using acute myeloid leukemia (AML) patient-derived xenografts, Farge and colleagues investigated the molecular mechanisms underlying resistance to the chemotherapeutic cytarabine (AraC) in vivo . Previous reports suggested that a refractory quiescent leukemic stem cell (LSC) population underlies AraC resistance, but AraC treatment unexpectedly reduced the number of LSCs as well as mature AML cells, indicating that AraC resistance is not mediated by LSCs . Instead, AraC induced chemoresistance by selecting for a preexisting population of resistant cells that exhibited enhanced oxidative phosphorylation (OXPHOS) . AraC-resistant cells showed elevated mitochondrial respiration, and blocking OXPHOS increased AraC sensitivity . Together, these findings demonstrate that high OXPHOS activity is associated with chemoresistance in AML and suggest the possibility that therapeutic targeting of mitochondrial metabolism may enhance chemosensitivity . For details, please see the article by Farge and colleagues on page 716 . 
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